Laboratory Corporation of America Holdings (0JSY.L)
USD 225.56
(2.93%)
USD 225.56
(2.93%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 418 Million USD | -67.32% |
| 2022 | 1.27 Billion USD | -46.2% |
| 2021 | 2.37 Billion USD | 52.77% |
| 2020 | 1.55 Billion USD | 88.89% |
| 2019 | 823.8 Million USD | -6.78% |
| 2018 | 883.7 Million USD | -30.32% |
| 2017 | 1.26 Billion USD | 73.23% |
| 2016 | 732.1 Million USD | 67.57% |
| 2015 | 436.9 Million USD | -14.53% |
| 2014 | 511.2 Million USD | -10.91% |
| 2013 | 573.8 Million USD | -1.59% |
| 2012 | 583.1 Million USD | 12.2% |
| 2011 | 519.7 Million USD | -6.9% |
| 2010 | 558.2 Million USD | 2.74% |
| 2009 | 543.3 Million USD | 16.96% |
| 2008 | 464.5 Million USD | -2.58% |
| 2007 | 476.8 Million USD | 10.47% |
| 2006 | 431.6 Million USD | 11.76% |
| 2005 | 386.2 Million USD | 6.39% |
| 2004 | 363 Million USD | 13.08% |
| 2003 | 321 Million USD | 26.08% |
| 2002 | 254.6 Million USD | 41.84% |
| 2001 | 179.5 Million USD | 60.12% |
| 2000 | 112.1 Million USD | 71.41% |
| 1999 | 65.4 Million USD | -4.94% |
| 1998 | 68.8 Million USD | 164.36% |
| 1997 | -106.9 Million USD | 30.36% |
| 1996 | -153.5 Million USD | -1147.97% |
| 1995 | -12.3 Million USD | -140.86% |
| 1994 | 30.1 Million USD | -73.29% |
| 1993 | 112.7 Million USD | 177.59% |
| 1992 | 40.6 Million USD | -60.92% |
| 1991 | 103.9 Million USD | 25.79% |
| 1990 | 82.6 Million USD | 27.67% |
| 1989 | 64.7 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 205.3 Million USD | -9.96% |
| 2024 Q2 | 169.3 Million USD | -17.54% |
| 2023 Q3 | -167.1 Million USD | -191.16% |
| 2023 Q2 | 183.3 Million USD | -2.96% |
| 2023 Q1 | 188.9 Million USD | -11.27% |
| 2023 Q4 | 228 Million USD | 236.45% |
| 2023 FY | 418 Million USD | -67.32% |
| 2022 FY | 1.27 Billion USD | -46.2% |
| 2022 Q1 | 358.6 Million USD | -27.05% |
| 2022 Q2 | 352.8 Million USD | -1.62% |
| 2022 Q3 | 76.1 Million USD | -78.43% |
| 2022 Q4 | 212.9 Million USD | 179.76% |
| 2021 Q1 | 467.4 Million USD | -39.27% |
| 2021 Q2 | 587.3 Million USD | 25.65% |
| 2021 Q3 | 553 Million USD | -5.84% |
| 2021 Q4 | 491.6 Million USD | -11.1% |
| 2021 FY | 2.37 Billion USD | 52.77% |
| 2020 FY | 1.55 Billion USD | 88.89% |
| 2020 Q3 | 938.3 Million USD | 33.39% |
| 2020 Q2 | 703.4 Million USD | 203.71% |
| 2020 Q4 | 769.6 Million USD | -17.98% |
| 2020 Q1 | 231.6 Million USD | 173.01% |
| 2019 Q3 | 227.1 Million USD | 2.9% |
| 2019 Q4 | -317.2 Million USD | -239.67% |
| 2019 FY | 823.8 Million USD | -6.78% |
| 2019 Q1 | 190.4 Million USD | 2.59% |
| 2019 Q2 | 220.7 Million USD | 15.91% |
| 2018 Q2 | 390.8 Million USD | 67.15% |
| 2018 FY | 883.7 Million USD | -30.32% |
| 2018 Q4 | 185.6 Million USD | 17.54% |
| 2018 Q3 | 157.9 Million USD | -59.6% |
| 2018 Q1 | 233.8 Million USD | 34.99% |
| 2017 Q4 | 173.2 Million USD | -75.5% |
| 2017 FY | 1.26 Billion USD | 73.23% |
| 2017 Q1 | 188.6 Million USD | -1.87% |
| 2017 Q3 | 706.8 Million USD | 291.36% |
| 2017 Q2 | 180.6 Million USD | -4.24% |
| 2016 FY | 732.1 Million USD | 67.57% |
| 2016 Q2 | 179.5 Million USD | -9.43% |
| 2016 Q4 | 192.2 Million USD | 4.23% |
| 2016 Q3 | 184.4 Million USD | 2.73% |
| 2016 Q1 | 198.2 Million USD | 23.72% |
| 2015 Q3 | 114.2 Million USD | -25.26% |
| 2015 FY | 436.9 Million USD | -14.53% |
| 2015 Q4 | 160.2 Million USD | 40.28% |
| 2015 Q1 | 168.4 Million USD | 23957.14% |
| 2015 Q2 | 152.8 Million USD | -9.26% |
| 2014 Q2 | 137.2 Million USD | -2.9% |
| 2014 Q1 | 141.3 Million USD | 24.93% |
| 2014 Q3 | 119.6 Million USD | -12.83% |
| 2014 FY | 511.2 Million USD | -10.91% |
| 2014 Q4 | 700 Thousand USD | -99.41% |
| 2013 Q2 | 148.3 Million USD | -2.37% |
| 2013 FY | 573.8 Million USD | -1.59% |
| 2013 Q4 | 113.1 Million USD | -10.45% |
| 2013 Q1 | 151.9 Million USD | 3.19% |
| 2013 Q3 | 126.3 Million USD | -14.83% |
| 2012 Q4 | 147.2 Million USD | 22.46% |
| 2012 FY | 583.1 Million USD | 12.2% |
| 2012 Q3 | 120.2 Million USD | -18.78% |
| 2012 Q2 | 148 Million USD | -3.46% |
| 2012 Q1 | 153.3 Million USD | -5.14% |
| 2011 Q4 | 161.6 Million USD | 19.35% |
| 2011 FY | 519.7 Million USD | -6.9% |
| 2011 Q3 | 135.4 Million USD | 0.82% |
| 2011 Q1 | 122.9 Million USD | -3.3% |
| 2011 Q2 | 134.3 Million USD | 9.28% |
| 2010 Q3 | 131.8 Million USD | -5.86% |
| 2010 FY | 558.2 Million USD | 2.74% |
| 2010 Q4 | 127.1 Million USD | -3.57% |
| 2010 Q1 | 153.7 Million USD | 15.83% |
| 2010 Q2 | 140 Million USD | -8.91% |
| 2009 FY | 543.3 Million USD | 16.96% |
| 2009 Q4 | 132.7 Million USD | -7.01% |
| 2009 Q3 | 142.7 Million USD | 8.6% |
| 2009 Q2 | 131.4 Million USD | -5.74% |
| 2009 Q1 | 139.4 Million USD | 4.97% |
| 2008 FY | 464.5 Million USD | -2.58% |
| 2008 Q4 | 132.8 Million USD | 12.45% |
| 2008 Q1 | 104.2 Million USD | -20.03% |
| 2008 Q2 | 111.9 Million USD | 7.39% |
| 2008 Q3 | 118.1 Million USD | 5.54% |
| 2007 Q3 | 114.4 Million USD | 2.88% |
| 2007 FY | 476.8 Million USD | 10.47% |
| 2007 Q1 | 128.7 Million USD | 5.06% |
| 2007 Q2 | 111.2 Million USD | -13.6% |
| 2007 Q4 | 130.3 Million USD | 13.9% |
| 2006 FY | 431.6 Million USD | 11.76% |
| 2006 Q4 | 122.5 Million USD | 18.13% |
| 2006 Q3 | 103.7 Million USD | -5.38% |
| 2006 Q2 | 109.6 Million USD | -5.84% |
| 2006 Q1 | 116.4 Million USD | 14.23% |
| 2005 Q3 | 88.9 Million USD | -6.12% |
| 2005 Q2 | 94.7 Million USD | -10.66% |
| 2005 Q4 | 101.9 Million USD | 14.62% |
| 2005 Q1 | 106 Million USD | 9.73% |
| 2005 FY | 386.2 Million USD | 6.39% |
| 2004 Q2 | 92.6 Million USD | -5.8% |
| 2004 FY | 363 Million USD | 13.08% |
| 2004 Q4 | 96.6 Million USD | 13.92% |
| 2004 Q1 | 98.3 Million USD | 12.6% |
| 2004 Q3 | 84.8 Million USD | -8.42% |
| 2003 Q1 | 86.4 Million USD | 16.91% |
| 2003 Q3 | 77.6 Million USD | -6.62% |
| 2003 Q2 | 83.1 Million USD | -3.82% |
| 2003 FY | 321 Million USD | 26.08% |
| 2003 Q4 | 87.3 Million USD | 12.5% |
| 2002 Q2 | 57.3 Million USD | -27.01% |
| 2002 Q1 | 78.5 Million USD | 19.3% |
| 2002 Q3 | 53 Million USD | -7.5% |
| 2002 Q4 | 73.9 Million USD | 39.43% |
| 2002 FY | 254.6 Million USD | 41.84% |
| 2001 FY | 179.5 Million USD | 60.12% |
| 2001 Q4 | 65.8 Million USD | 61.27% |
| 2001 Q3 | 40.8 Million USD | -5.34% |
| 2001 Q1 | 52.1 Million USD | 19.77% |
| 2001 Q2 | 43.1 Million USD | -17.27% |
| 2000 Q4 | 43.5 Million USD | 108.13% |
| 2000 Q1 | 32.7 Million USD | 27.24% |
| 2000 FY | 112.1 Million USD | 71.41% |
| 2000 Q2 | 32.8 Million USD | 0.31% |
| 2000 Q3 | 20.9 Million USD | -36.28% |
| 1999 Q2 | 17.2 Million USD | -13.13% |
| 1999 FY | 65.4 Million USD | -4.94% |
| 1999 Q4 | 25.7 Million USD | 80.99% |
| 1999 Q3 | 14.2 Million USD | -17.44% |
| 1999 Q1 | 19.8 Million USD | 40.43% |
| 1998 Q3 | 35.3 Million USD | 209.65% |
| 1998 Q2 | 11.4 Million USD | -10.94% |
| 1998 Q4 | 14.1 Million USD | -60.06% |
| 1998 Q1 | 12.8 Million USD | 37.63% |
| 1998 FY | 68.8 Million USD | 164.36% |
| 1997 Q1 | 4.1 Million USD | 70.83% |
| 1997 FY | -106.9 Million USD | 30.36% |
| 1997 Q4 | 9.3 Million USD | 107.83% |
| 1997 Q3 | -118.7 Million USD | -2298.15% |
| 1997 Q2 | 5.4 Million USD | 31.71% |
| 1996 Q1 | -14.2 Million USD | -340.68% |
| 1996 FY | -153.5 Million USD | -1147.97% |
| 1996 Q4 | 2.4 Million USD | 100.0% |
| 1996 Q3 | 1.2 Million USD | 100.82% |
| 1996 Q2 | -146.4 Million USD | -930.99% |
| 1995 Q2 | 14.4 Million USD | 136.09% |
| 1995 Q4 | 5.9 Million USD | 1375.0% |
| 1995 Q1 | -39.9 Million USD | -411.72% |
| 1995 FY | -12.3 Million USD | -140.86% |
| 1995 Q3 | 400 Thousand USD | -97.22% |
| 1994 Q4 | 12.8 Million USD | 66.23% |
| 1994 Q2 | 200 Thousand USD | -98.58% |
| 1994 Q1 | 14.1 Million USD | 74.07% |
| 1994 FY | 30.1 Million USD | -73.29% |
| 1994 Q3 | 7.7 Million USD | 3750.0% |
| 1993 Q1 | 33.2 Million USD | -1.19% |
| 1993 Q4 | 8.1 Million USD | 5.19% |
| 1993 Q3 | 7.7 Million USD | -79.84% |
| 1993 Q2 | 38.2 Million USD | 15.06% |
| 1993 FY | 112.7 Million USD | 177.59% |
| 1992 Q3 | -50.6 Million USD | -268.11% |
| 1992 Q1 | 31.4 Million USD | 5.72% |
| 1992 Q2 | 30.1 Million USD | -4.14% |
| 1992 FY | 40.6 Million USD | -60.92% |
| 1992 Q4 | 33.6 Million USD | 166.4% |
| 1991 Q4 | 29.7 Million USD | 10.82% |
| 1991 FY | 103.9 Million USD | 25.79% |
| 1991 Q2 | 25.6 Million USD | -5.19% |
| 1991 Q3 | 26.8 Million USD | 4.69% |
| 1991 Q1 | 27 Million USD | 10.2% |
| 1990 Q4 | 24.5 Million USD | 16.67% |
| 1990 Q2 | 20.2 Million USD | -6.05% |
| 1990 FY | 82.6 Million USD | 27.67% |
| 1990 Q1 | 21.5 Million USD | 8.04% |
| 1990 Q3 | 21 Million USD | 3.96% |
| 1989 Q3 | 16.9 Million USD | 13.42% |
| 1989 FY | 64.7 Million USD | 0.0% |
| 1989 Q4 | 19.9 Million USD | 17.75% |
| 1989 Q1 | 17.1 Million USD | 8.23% |
| 1989 Q2 | 14.9 Million USD | -12.87% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 405.366% |
| Accuray Incorporated | -15.54 Million USD | 2788.968% |
| Align Technology, Inc. | 445.05 Million USD | 6.079% |
| Elevance Health Inc. | 5.98 Billion USD | 93.018% |
| AxoGen, Inc. | -21.71 Million USD | 2024.848% |
| Boston Scientific Corporation | 1.59 Billion USD | 73.76% |
| CVS Health Corporation | 8.34 Billion USD | 94.99% |
| Cardinal Health, Inc. | 852 Million USD | 50.939% |
| Centene Corporation | 2.7 Billion USD | 84.53% |
| DaVita Inc. | 691.53 Million USD | 39.555% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 92.026% |
| Hologic, Inc. | 789.5 Million USD | 47.055% |
| Humana Inc. | 2.48 Billion USD | 83.206% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 50.535% |
| Masimo Corporation | 81.5 Million USD | -412.883% |
| McKesson Corporation | 3 Billion USD | 86.076% |
| Patterson Companies, Inc. | 185.93 Million USD | -124.815% |
| Quest Diagnostics Incorporated | 854 Million USD | 51.054% |
| ResMed Inc. | 1.02 Billion USD | 59.058% |
| Henry Schein, Inc. | 416 Million USD | -0.481% |
| Teladoc Health, Inc. | -220.36 Million USD | 289.683% |
| Universal Health Services, Inc. | 717.79 Million USD | 41.766% |
| Veeva Systems Inc. | 525.7 Million USD | 20.488% |
| Baxter International Inc. | 2.65 Billion USD | 84.262% |
| Becton, Dickinson and Company | 1.48 Billion USD | 71.833% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 76.752% |
| Danaher Corporation | 4.2 Billion USD | 90.048% |
| Stryker Corporation | 3.16 Billion USD | 86.793% |
| Medtronic plc | 3.67 Billion USD | 88.629% |